MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3′-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein*

N6-Methyladenosine (m6A) is a prevalent modification present in the mRNAs of higher eukaryotes. YTH domain family 2 (YTHDF2), an m6A “reader” protein, can recognize mRNA m6A sites to mediate mRNA degradation. However, the regulatory mechanism of YTHDF2 is poorly understood. To this end, we investigated the post-transcriptional regulation of YTHDF2. Bioinformatics analysis suggested that the microRNA miR-145 might target the 3′-untranslated region (3′-UTR) of YTHDF2 mRNA. The levels of miR-145 were negatively correlated with those of YTHDF2 mRNA in clinical hepatocellular carcinoma (HCC) tissues, and immunohistochemical staining revealed that YTHDF2 was closely associated with malignancy of HCC. Interestingly, miR-145 decreased the luciferase activities of 3′-UTR of YTHDF2 mRNA. Mutation of predicted miR-145 binding sites in the 3′-UTR of YTHDF2 mRNA abolished the miR-145-induced decrease in luciferase activity. Overexpression of miR-145 dose-dependently down-regulated YTHDF2 expression in HCC cells at the levels of both mRNA and protein. Conversely, inhibition of miR-145 resulted in the up-regulation of YTHDF2 in the cells. Dot blot analysis and immunofluorescence staining revealed that the overexpression of miR-145 strongly increased m6A levels relative to those in control HCC cells, and this increase could be blocked by YTHDF2 overexpression. Moreover, miR-145 inhibition strongly decreased m6A levels, which were rescued by treatment with a small interfering RNA-based YTHDF2 knockdown. Thus, we conclude that miR-145 modulates m6A levels by targeting the 3′-UTR of YTHDF2 mRNA in HCC cells.

[1]  N. Dong,et al.  The role of miR-145 in microvasculature. , 2013, Die Pharmazie.

[2]  O. Elemento,et al.  Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons , 2012, Cell.

[3]  N. Seki,et al.  SWAP70, actin‐binding protein, function as an oncogene targeting tumor‐suppressive miR‐145 in prostate cancer , 2011, The Prostate.

[4]  F. Bock,et al.  Poly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer. , 2015, Trends in molecular medicine.

[5]  Jie Zheng,et al.  Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2 , 2010, Cell Research.

[6]  Radhika Das,et al.  Role of the N6-methyladenosine RNA mark in gene regulation and its implications on development and disease. , 2015, Briefings in functional genomics.

[7]  E. Lai,et al.  Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. , 2011, Molecular cell.

[8]  Yun-Gui Yang,et al.  N6-methyl-adenosine (m6A) in RNA: An Old Modification with A Novel Epigenetic Function , 2012, Genom. Proteom. Bioinform..

[9]  Yumei Du,et al.  Hepatitis B virus X protein protects hepatoma and hepatic cells from complement‐dependent cytotoxicity by up‐regulation of CD46 , 2013, FEBS letters.

[10]  M. Hastings m6A mRNA Methylation: A New Circadian Pacesetter , 2013, Cell.

[11]  A. Pasquinelli,et al.  MicroRNA biogenesis: regulating the regulators , 2013, Critical reviews in biochemistry and molecular biology.

[12]  Jun Yan,et al.  MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells. , 2012, Biochemical and biophysical research communications.

[13]  Arne Klungland,et al.  ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. , 2013, Molecular cell.

[14]  Yue Zhang,et al.  MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma , 2016, Tumor Biology.

[15]  G. Rechavi,et al.  FTO: linking m6A demethylation to adipogenesis , 2014, Cell Research.

[16]  Chuan He,et al.  FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis , 2014, Cell Research.

[17]  Zhi-mao Jiang,et al.  miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma , 2014, Journal of Cancer Research and Clinical Oncology.

[18]  Y. Zhang,et al.  The Oncoprotein HBXIP Uses Two Pathways to Up-regulate S100A4 in Promotion of Growth and Migration of Breast Cancer Cells* , 2012, The Journal of Biological Chemistry.

[19]  Chengqi Yi,et al.  N6-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO , 2011, Nature chemical biology.

[20]  Claudio Franceschi,et al.  A polymorphism of the YTHDF2 gene (1p35) located in an Alu-rich genomic domain is associated with human longevity. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[21]  Samir Adhikari,et al.  Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase , 2014, Cell Research.

[22]  C. Creighton,et al.  Overexpression of miR-145–5p Inhibits Proliferation of Prostate Cancer Cells and Reduces SOX2 Expression , 2015, Cancer investigation.

[23]  H. Soifer,et al.  MicroRNAs in disease and potential therapeutic applications. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  J. Vandesompele,et al.  Identification of miR-145 as a key regulator of the pigmentary process. , 2013, The Journal of investigative dermatology.

[25]  Shu-Bing Qian,et al.  Dynamic m6A mRNA methylation directs translational control of heat shock response , 2015, Nature.

[26]  P. Sharp,et al.  The role of miRNAs in regulating gene expression networks. , 2013, Journal of molecular biology.

[27]  N. Wong,et al.  MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. , 2012, Carcinogenesis.

[28]  Ligang Wu,et al.  YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex , 2016, Nature Communications.

[29]  E. Olson,et al.  A Role for miR-145 in Pulmonary Arterial Hypertension: Evidence From Mouse Models and Patient Samples , 2012, Circulation research.

[30]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[31]  Yumei Du,et al.  Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack. , 2011, Carcinogenesis.

[32]  Chuan He,et al.  N 6 -methyladenosine Modulates Messenger RNA Translation Efficiency , 2015, Cell.

[33]  J. Doudna,et al.  A three-dimensional view of the molecular machinery of RNA interference , 2009, Nature.

[34]  Youliang Wang,et al.  Hepatitis B virus X protein modulates oncogene yes‐associated protein by CREB to promote growth of hepatoma cells , 2012, Hepatology.

[35]  Shu‐hong Li,et al.  Role of miR-145 in cardiac myofibroblast differentiation. , 2014, Journal of molecular and cellular cardiology.

[36]  Tao Zhang,et al.  Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells. , 2013, Carcinogenesis.

[37]  Sheng Li,et al.  The pivotal regulatory landscape of RNA modifications. , 2014, Annual review of genomics and human genetics.

[38]  Chen Hu,et al.  MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling. , 2014, Biochemical and biophysical research communications.

[39]  Bing Ren,et al.  N6-methyladenosine-dependent regulation of messenger RNA stability , 2013 .

[40]  Q. Hao,et al.  MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1. , 2013, Biochemical and biophysical research communications.

[41]  Xihong Zhou,et al.  FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice , 2015, Journal of Physiology and Biochemistry.

[42]  Qun Zhou,et al.  lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6 , 2014, Molecular Cancer Research.

[43]  Zhike Lu,et al.  m6A-dependent regulation of messenger RNA stability , 2013, Nature.

[44]  Jian-Jun Wei,et al.  miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma , 2014, Oncotarget.

[45]  Feng Wang,et al.  miR-145 Inhibits Proliferation and Invasion of Esophageal Squamous Cell Carcinoma in Part by Targeting c-Myc , 2013, Onkologie.

[46]  R. Shiekhattar,et al.  MicroRNA biogenesis: isolation and characterization of the microprocessor complex. , 2006, Methods in molecular biology.

[47]  Yu Zhao,et al.  The Nuclear Import of Oncoprotein Hepatitis B X-interacting Protein Depends on Interacting with c-Fos and Phosphorylation of Both Proteins in Breast Cancer Cells , 2013, The Journal of Biological Chemistry.

[48]  Jiejie Xu,et al.  EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma , 2015, Nature Communications.

[49]  Christopher E. Mason,et al.  Novel RNA regulatory mechanisms revealed in the epitranscriptome , 2013, RNA biology.

[50]  T. Pan N6-methyl-adenosine modification in messenger and long non-coding RNA. , 2013, Trends in biochemical sciences.

[51]  Yong-hong Gu,et al.  MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1 , 2015, Digestive Diseases and Sciences.

[52]  Thomas Preiss,et al.  Mapping and significance of the mRNA methylome , 2013, Wiley interdisciplinary reviews. RNA.